Abingdon Health is a UK-based diagnostics group focused on developing, manufacturing and commercializing immunoassay tests and reader systems. We provide lateral flow assay development and ...
AblaCare develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility, designed to provide patients with a more natural and less medicalised pregnancy experience.
Ablynx’s proprietary Nanobody platform allows for the rapid generation and large-scale production of novel biological therapeutics that have potential in a wide range of human diseases.
The ABPDU enables early stage advanced biofuels, biomaterials, and biochemicals product and process technologies to successfully scale from the lab to commercial relevance.
Abraxis develops, manufactures, and markets rapid environmental, food, and life sciences test systems, including immunochemistry products and methods, to meet the testing needs of research and ...
Biopharmaceutical protein manufacturing. The company has an all-in-one protein expression platform which it uses to produce complex proteins ranging from full-length antibodies to insulin using ...
Acarix A/S is based on pioneering research performed at the Aalborg University, Denmark, initiated in 2004. The CADScor system is designed to significantly decrease the cost of the Coronary Artery ...
The ACC Bioscience Incubator provides leasable wet lab space and equipment and helps start up companies with business development and workforce education.
Accelerated Pharma is a clinical-stage pharmaceutical company whose drug development strategy is based on individualized targeting of patients using genomics.
Accelerated Technology Laboratories, Inc. (ATL) develops Laboratory Information Management System (LIMS) software, and provides consulting services, technical support and hands-on training to ...
Accelergy uses advanced catalysts and state-of-the-art process technologies to transform natural gas, biomass, and/or coal into clean specialty products and transportation fuels. Accelergy’s state ...
